Q4 2022 Bactiguard Holding AB Earnings Call Transcript
Welcome to the Bactiguard Q4 conference call. (Operator Instructions) Now I will hand the conference over to the speakers, CEO, Anders Göransson; and CFO, Carin Jakobson. Please go ahead.
¶ -
Welcome to all our shareholders, investors, and analysts in today's call. Today, we will share our Q4 and 2022 results.
Reflecting on the year, it has been a year of transformation for Bactiguard. In the beginning of the year, we launched a new focused growth strategy and set new long-term financial goals. And since then, we have invested in our organization to realize the full potential of our infection prevention offering, including signing a starting product development with two new partners during 2022, or in two new partnerships, I should say.
If I go to page 3 and look at 2022 in brief, first, we had a strong year with revenue increase of 42%, and in quarter four, it was 57%. And this is despite the bumpy macroeconomics post-COVID related issues, still affecting healthcare systems in part
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |